Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.530
-0.130 (-7.83%)
At close: Jun 12, 2026, 4:00 PM EDT
1.620
+0.090 (5.88%)
Pre-market: Jun 15, 2026, 7:19 AM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $5.63 million as of June 15, 2026. Its market cap has increased by 88.36% in one year.
Market Cap
5.63M
Enterprise Value
724.51K
1-Year Change
88.36%
Ranking
Category
Stock Price
$1.53
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $5.63M, a decrease of -100.00%. That is a compound annual growth rate of -84.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 5.63M | 51.64% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Can-Fite BioPharma | 6.23M |
| Evogene | 6.01M |
| Cardio Diagnostics Holdings | 5.80M |
| Processa Pharmaceuticals | 5.77M |
| Aptevo Therapeutics | 5.65M |
| Mustang Bio | 5.60M |
| XTL Biopharmaceuticals | 5.51M |
| Liminatus Pharma | 5.48M |